Advertisement

PharmacoEconomics

, Volume 37, Issue 5, pp 739–739 | Cite as

Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal

  • Lindsay ClaxtonEmail author
  • Joanne O’Connor
  • Nerys Woolacott
  • Kath Wright
  • Robert Hodgson
Correction

1 Correction to: PharmacoEconomics  https://doi.org/10.1007/s40273-018-0720-8

The title of the article should read:

Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal.

The original article was corrected.

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.Centre for Reviews and DisseminationUniversity of YorkYorkUK

Personalised recommendations